These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 30470618)

  • 1. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis.
    Acero-Garcés DO; García-Perdomo HA
    Curr Pediatr Rev; 2020; 16(1):61-70. PubMed ID: 31656149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
    Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
    Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
    Ozsoylu S; Sayli TR; Oztürk G
    Pediatr Hematol Oncol; 1993; 10(4):317-21. PubMed ID: 8292515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
    Duru F; Fisgin T; Yarali N; Kara A
    Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
    Cooper N
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune thrombocytopenic purpura.
    Gupta V; Tilak V; Bhatia BD
    Indian J Pediatr; 2008 Jul; 75(7):723-8. PubMed ID: 18716743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.
    Pruemer J
    Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S4-10. PubMed ID: 19139489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of immune thrombocytopenic purpura in children: potential role of novel agents.
    Bredlau AL; Semple JW; Segel GB
    Paediatr Drugs; 2011 Aug; 13(4):213-23. PubMed ID: 21692546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura in Egyptian children.
    Khalifa AS; Tolba KA; el-Alfy MS; Gadallah M; Ibrahim FH
    Acta Haematol; 1993; 90(3):125-9. PubMed ID: 8291370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
    Higashide Y; Hori T; Yoto Y; Kabutoya H; Honjo S; Sakai Y; Nojima M; Yoda M; Yamamoto M; Tsutsumi H
    Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent immune thrombocytopenic purpura in children.
    Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.